As healthcare systems in Europe shift towards value-based approaches in response to ageing populations and increased budget pressures, pharma companies must adapt if they want to remain a relevant player. Pharma companies need to show that they deliver value to patients. Value-based healthcare (VBHC) is an approach that focuses on delivering high-quality outcomes to patients while considering the efficient use of healthcare resources.
